DrugBaron

FEBRUARY 7, 2022

Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. Yet the situation with small molecules is even worse.

Small Molecule 100

Small Molecule Synthetic Chemistry Pharma Companies Pharmacokinetics 100

The Strateos Blog: Drug Discovery

SEPTEMBER 24, 2021

On September 15th, Strateos hosted Part 2 of its Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis. Ben Miles, Ph.D., Head of Product Management at Strateos was joined by Josh Bond, Director of Product Management at PerkinElmer Informatics to discuss this exciting collaboration. Ben Miles, Ph.D.,

Synthetic Chemistry 52

Synthetic Chemistry Small Molecule Production Science 52

Dark Matter Blog

APRIL 8, 2020

The second is that while it may be hard to achieve molecular recognition, it’s even harder to make a drug, which is to say a molecule that you can eat, that distributes throughout the body, and survives long enough to find its target. Consequently, we were going to stick to chemical space where we know real drugs live.

RNA 52

RNA Small Molecule Synthetic Chemistry Science 52

The Pharma Data

DECEMBER 4, 2021

As a result, Pfizer can maximize uptime for equipment such as centrifuges, agitators, pulverizers, coaters, and air handlers used in clinical drug manufacturing. The overall focus of this collaboration is to support Pfizer in more rapidly and reliably producing new drugs and evaluating their potential health benefit for patients.

Drug Development 52

Drug Development Small Molecule Synthetic Chemistry Drugs 52

The Strateos Blog: Drug Discovery

AUGUST 16, 2021

On July 20th, Strateos hosted a webinar entitled Drug Discovery and Medicinal Chemistry in the Era of Automation. To advance a lead candidate through to clinical trials in traditional small molecule pipelines, it can take on average 6+ years. Daniel Rines, Ph.D., Director of R&D Strategy and Vince Yeh, Ph.D.,

Synthetic Chemistry 52

Synthetic Chemistry Small Molecule Drugs Clinical Trials 52

The Strateos Blog: Drug Discovery

FEBRUARY 22, 2022

Strateos’ SVP of Strategy & Operations, Daniel Sipes, echoed this sentiment during his presentation on how automated labs are accelerating medicinal chemistry (MedChem) cycles for drug discovery. The model quality data generated is well-suited to support AI and machine learning tools.”

Small Molecule 52

Small Molecule Laboratories Science Production 52